What does Dr. Heylbroeck Ph., NKO do?

Dr. Heylbroeck Ph., NKO is a specialist medical practice in Sint-Martens-Latem. Private Limited, started on 29 June 2007, 1 establishment.

What is the address of Dr. Heylbroeck Ph., NKO?

The registered office of Dr. Heylbroeck Ph., NKO is located at Nelemeersstraat 38/A, 9830 Sint-Martens-Latem.

Is Dr. Heylbroeck Ph., NKO still active?

Yes. According to the CBE (18 September 2026) Dr. Heylbroeck Ph., NKO is active, legal situation “Normale toestand”, started on 29 June 2007.

Is Dr. Heylbroeck Ph., NKO registered on Peppol?

Yes, Dr. Heylbroeck Ph., NKO is registered on the Peppol network with ID 0208:0890469995.

What is the enterprise number of Dr. Heylbroeck Ph., NKO?

The enterprise number of Dr. Heylbroeck Ph., NKO is BE0890469995.

When was Dr. Heylbroeck Ph., NKO founded?

Dr. Heylbroeck Ph., NKO was founded on 29 June 2007.

Who are the directors of Dr. Heylbroeck Ph., NKO?

According to the 2025 annual accounts, the directors of Dr. Heylbroeck Ph., NKO are: Philippe Heylbroeck.

Is Dr. Heylbroeck Ph., NKO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 June 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Heylbroeck Ph., NKO make in 2025?

Dr. Heylbroeck Ph., NKO posted a profit after taxes of € 252,174 in financial year 2025.

What is the revenue of Dr. Heylbroeck Ph., NKO?

As a small company, Dr. Heylbroeck Ph., NKO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 384,550.

Dr. Heylbroeck Ph., NKO (Private Limited)

Dossier Dr. Heylbroeck Ph., NKO, printed on 18 September 2026 from databakkes.be/en/0890469995/dr-heylbroeck-ph-nko. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Heylbroeck Ph., NKO from Sint-Martens-Latem, company number BE0890469995, closed financial year 2025 with a result of € 252,174 after tax. For that financial year Dr. Heylbroeck Ph., NKO recorded a gross margin of € 384,550 and equity of € 559,912. Compared with financial year 2024, the result moved from € 139,919 to € 252,174. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 13, 2026.

What it is worth Growing

€ 559,912

▲ 51% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 252,174

▲ 80% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 519,088

▲ € 480,244 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 62,500 paid out

25 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 14,593

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 4,872

▲ 28% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 28,704

▲ 27% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 84,758 Gross margin 2022: € 84,758 First fiscal year in the series	€ 125,922 Gross margin 2023: € 125,922 ▲ 49% vs 2022 (€ 84,758) Favourable step	€ 210,638 Gross margin 2024: € 210,638 ▲ 67% vs 2023 (€ 125,922) Favourable step	€ 384,550 Gross margin 2025: € 384,550 ▲ 83% vs 2024 (€ 210,638) Favourable step	▲ 83%
Profit after taxes	€ 49,108 Profit after taxes 2022: € 49,108 First fiscal year in the series	€ 77,859 Profit after taxes 2023: € 77,859 ▲ 59% vs 2022 (€ 49,108) Favourable step	€ 139,919 Profit after taxes 2024: € 139,919 ▲ 80% vs 2023 (€ 77,859) Favourable step	€ 252,174 Profit after taxes 2025: € 252,174 ▲ 80% vs 2024 (€ 139,919) Favourable step	▲ 80%
Equity	€ 190,460 Equity 2022: € 190,460 First fiscal year in the series	€ 268,319 Equity 2023: € 268,319 ▲ 41% vs 2022 (€ 190,460) Favourable step	€ 370,237 Equity 2024: € 370,237 ▲ 38% vs 2023 (€ 268,319) Favourable step	€ 559,912 Equity 2025: € 559,912 ▲ 51% vs 2024 (€ 370,237) Favourable step	▲ 51%
Total debts	€ 14,164 Total debts 2022: € 14,164 First fiscal year in the series	€ 19,618 Total debts 2023: € 19,618 ▲ 39% vs 2022 (€ 14,164) Unfavourable step	€ 28,370 Total debts 2024: € 28,370 ▲ 45% vs 2023 (€ 19,618) Unfavourable step	€ 34,094 Total debts 2025: € 34,094 ▲ 20% vs 2024 (€ 28,370) Unfavourable step	▲ 20%
Cash	€ 44,131 Cash 2022: € 44,131 First fiscal year in the series	€ 66,121 Cash 2023: € 66,121 ▲ 50% vs 2022 (€ 44,131) Favourable step	€ 38,844 Cash 2024: € 38,844 ▼ 41% vs 2023 (€ 66,121) Unfavourable step	€ 519,088 Cash 2025: € 519,088 ▲ € 480,244 vs 2024 (€ 38,844) Favourable step	▲ € 480,244
Land & buildings	€ 26,941 Land & buildings 2022: € 26,941 First fiscal year in the series	€ 22,685 Land & buildings 2023: € 22,685 ▼ 16% vs 2022 (€ 26,941) Unchanged	€ 18,430 Land & buildings 2024: € 18,430 ▼ 19% vs 2023 (€ 22,685) Unchanged	€ 14,175 Land & buildings 2025: € 14,175 ▼ 23% vs 2024 (€ 18,430) Unchanged	▼ 23%
Retained profit	€ 178,060 Retained profit 2022: € 178,060 First fiscal year in the series	€ 255,919 Retained profit 2023: € 255,919 ▲ 44% vs 2022 (€ 178,060) Favourable step	€ 357,837 Retained profit 2024: € 357,837 ▲ 40% vs 2023 (€ 255,919) Favourable step	€ 547,512 Retained profit 2025: € 547,512 ▲ 53% vs 2024 (€ 357,837) Favourable step	▲ 53%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 38,000 Dividend 2024: € 38,000 Unchanged (€ 0) Unchanged	€ 62,500 Dividend 2025: € 62,500 ▲ 64% vs 2024 (€ 38,000) Unchanged	▲ 64%
Balance sheet total	€ 204,624 Balance sheet total 2022: € 204,624 First fiscal year in the series	€ 287,937 Balance sheet total 2023: € 287,937 ▲ 41% vs 2022 (€ 204,624) Unchanged	€ 398,607 Balance sheet total 2024: € 398,607 ▲ 38% vs 2023 (€ 287,937) Unchanged	€ 594,006 Balance sheet total 2025: € 594,006 ▲ 49% vs 2024 (€ 398,607) Unchanged	▲ 49%

Key figures of Dr. Heylbroeck Ph., NKO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Heylbroeck Ph., NKO?

What happened at Dr. Heylbroeck Ph., NKO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 13, 2026 New annual accounts for financial year 2025: profit of € 252,174 (▲ 80% vs 2024). Source: NBB ↗
Jun 30, 2009 New establishment in Gent. KBO
Jun 29, 2007 Start of the company according to the CBE. KBO
2007 Philippe Heylbroeck became a director. NBB

In short

From € 49,108 profit in 2022 to € 252,174 profit in 2025.

Paid € 235,787 in corporate taxes since 2022.

Best year ever: 2025, with € 252,174 profit.

Paid out € 100,500 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Heylbroeck Ph., NKO? We notify you, reason included.

Follow Dr. Heylbroeck Ph., NKO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Philippe Heylbroeck

Dr. Heylbroeck Ph., NKO

Behind Dr. Heylbroeck Ph., NKO is Philippe Heylbroeck.

See the full network in the app

Directors

According to the 2025 annual accounts

Philippe Heylbroeck

Director

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Nelemeersstraat 38/A

9830 Sint-Martens-Latem

2.192.004.614

Coupure 323

9000 Gent

Active since 30 June 2009

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0890.469.995
VAT number: BE 0890.469.995
Registered office: Nelemeersstraat 38/A, 9830 Sint-Martens-Latem
Names & denominations: Dr. Heylbroeck Ph., NKO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 June 2007
Peppol: Active · Active since 18 Nov 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗